Literature DB >> 28622621

Development of an ultra-fast liquid chromatography-tandem mass spectrometry method for simultaneous determination of seven flavonoids in rat plasma: Application to a comparative pharmacokinetic investigation of Ginkgo biloba extract and single pure ginkgo flavonoids after oral administration.

Tianyang Wang1, Jie Xiao1, Huiping Hou1, Pei Li1, Ziyue Yuan1, Huarong Xu1, Ran Liu1, Qing Li1, Kaishun Bi2.   

Abstract

For deeper pharmacokinetic investigation and further curative application of ginkgo flavonoids, a delicate, efficient and precise UFLC-MS/MS technique for synchronous quantitation of seven flavonoids, apigenin, luteolin, naringenin, quercetin, diosmetin, kaempferol and isorhamnetin in rat plasma has been established. After mixing with the internal standard (IS) linarin, bio-samples were pretreated via ethyl acetate for liquid-liquid extraction, then isolated at 0.2ml/min flow rate on a Venusil MP C18 chromatographic column (100mm×2.1mm, 3μm) by means of gradient elution. 0.1% formic acid-water and methanol system was used as the mobile phase. Mass spectrometric inspection was conducted on a 4000Q UFLC-MS/MS system with turbo ion spray source in patterns of negative ion and multiple reaction-monitoring (MRM). All calibration curves proved favorable linearity (R2≥0.9918) in linear ranges. Intra-day and inter-day precisions didn't exceed 14.0% for all the analytes, and the accuracy was within 6.9%. Extraction recoveries of analytes and IS were less than ±15.0% of nominal concentrations. This method has been under thorough and firm verification for a comparative pharmacokinetic research after gavage between Ginkgo biloba extract and single pure ginkgo flavonoids. The results demonstrated that there're evident pharmacokinetic discrepancies, and possible structural influences were innovatively proposed. Generally, substitution with 3-hydroxylation, a double bond in ring C, ring B methoxylation often confer longer onset period. The existence of ring B catechol group gives rise to faster clearance.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Flavonoid; Ginkgo biloba extract; Pharmacokinetics; UFLC–MS/MS

Mesh:

Substances:

Year:  2017        PMID: 28622621     DOI: 10.1016/j.jchromb.2017.05.021

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  3 in total

1.  Study on Integrated Pharmacokinetics of the Component-Based Chinese Medicine of Ginkgo biloba Leaves Based on Nanocrystalline Solid Dispersion Technology.

Authors:  Hongbao Liang; Chenghong Sun; Zhong Feng; Xianzhen Wang; Lingpeng Kong; Feng Zhu; Jingchun Yao; Xiaomei Yuan; Zhong Liu; Guimin Zhang; Feng Li
Journal:  Int J Nanomedicine       Date:  2022-09-08

2.  Pharmacokinetic study of Tangwang Mingmu granule for the management of diabetic retinopathy based on network pharmacology.

Authors:  Yucheng Wang; Beibei Xue; Xiaoli Wang; Qilong Wang; Erwei Liu; Xiaopeng Chen
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

Review 3.  Pharmacokinetic, Metabolism, and Metabolomic Strategies Provide Deep Insight Into the Underlying Mechanism of Ginkgo biloba Flavonoids in the Treatment of Cardiovascular Disease.

Authors:  Yi Tao; Fei Zhu; Meiling Pan; Qing Liu; Ping Wang
Journal:  Front Nutr       Date:  2022-03-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.